We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$439M
AUM Growth
+$22.7M
Cap. Flow
+$1.23M
Cap. Flow %
0.28%
Top 10 Hldgs %
18.86%
Holding
332
New
121
Increased
28
Reduced
53
Closed
100

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.29M
2
AXP icon
American Express
AXP
+$7.22M
3
CVS icon
CVS Health
CVS
+$4.98M
4
DVN icon
Devon Energy
DVN
+$4.92M
5
AMP icon
Ameriprise Financial
AMP
+$4.87M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$8.18M
2
CB icon
Chubb
CB
+$7.62M
3
NSC icon
Norfolk Southern
NSC
+$7.16M
4
PSA icon
Public Storage
PSA
+$7.08M
5
CPB icon
Campbell Soup
CPB
+$6.99M

Sector Composition

Rank Sector Weight
1 Technology 16.64%
2 Financials 14.44%
3 Healthcare 13.99%
4 Industrials 11.57%
5 Energy 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIVB
326
DELISTED
SVB Financial Group
SIVB
-24,515
Closed -$3.16M
NSU
327
DELISTED
Nevsun Resources Ltd.
NSU
-77,400
Closed -$261K
BBOX
328
DELISTED
Black Box Corp
BBOX
-6,145
Closed -$150K
LPNT
329
DELISTED
LifePoint Health, Inc.
LPNT
-4,150
Closed -$226K
SPLS
330
DELISTED
Staples Inc
SPLS
-316,950
Closed -$3.59M
LXK
331
DELISTED
Lexmark Intl Inc
LXK
-81,160
Closed -$3.76M
SWFT
332
DELISTED
Swift Transportation Company
SWFT
-8,665
Closed -$214K

Similar funds

C.M. Bidwell & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, C.M. Bidwell & Associates held 332 positions worth $439M, up 5.5% from $416M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

C.M. Bidwell & Associates's Q2 2014 filing shows 121 new, 28 increased, 53 reduced and 100 closed positions. Its largest new stake was Gilead Sciences: 93,610 shares worth $7.76M. The largest sale was Charles Schwab, an estimated $8.18M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • C.M. Bidwell & Associates's largest Q2 2014 buy was Gilead Sciences: 93,610 shares worth $7.76M.
  • C.M. Bidwell & Associates added most to CVS Health in Q2 2014, an estimated $4.98M increase.
  • C.M. Bidwell & Associates's biggest Q2 2014 reduction was Chubb, cutting an estimated $7.62M.
  • C.M. Bidwell & Associates fully exited Charles Schwab in Q2 2014, selling an estimated $8.18M.
  • C.M. Bidwell & Associates's ten largest holdings make up 19% of its $439M portfolio in Q2 2014.
  • C.M. Bidwell & Associates opened 121 new positions and closed 100 in Q2 2014.
  • C.M. Bidwell & Associates's portfolio value rose 5.5% quarter-over-quarter to $439M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2014, filed 12 Aug 2014.